Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alfred K Cheung

Showing results (221-230 of 262) with videos related to

Pageof 27
Sort By:
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|September 20, 2021
Kidney Disease, Hypertension Treatment, and Cerebral Perfusion and StructureManjula Kurella Tamura, Sarah Gaussoin, Nicholas M Pajewski, et al.
Circulation|October 13, 2017
Influence of Baseline Diastolic Blood Pressure on Effects of Intensive Compared With Standard Blood Pressure ControlSrinivasan Beddhu, Glenn M Chertow, Alfred K Cheung, et al.
Annals of Internal Medicine|September 5, 2017
Effects of Intensive Systolic Blood Pressure Control on Kidney and Cardiovascular Outcomes in Persons Without Kidney Disease: A Secondary Analysis of a Randomized TrialSrinivasan Beddhu, Michael V Rocco, Robert Toto, et al.
Clinical Journal of the American Society of Nephrology : CJASN|April 30, 2020
Kidney Functional Magnetic Resonance Imaging and Change in eGFR in Individuals with CKDAnand Srivastava, Xuan Cai, Jungwha Lee, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|November 17, 2021
Plasma amyloid beta, neurofilament light chain, and total tau in the Systolic Blood Pressure Intervention Trial (SPRINT)Nicholas M Pajewski, Fanny M Elahi, Manjula Kurella Tamura, et al.
Clinical Journal of the American Society of Nephrology : CJASN|November 15, 2018
PTH, FGF23, and Intensive Blood Pressure Lowering in Chronic Kidney Disease Participants in SPRINTCharles Ginsberg, Timothy E Craven, Michel B Chonchol, et al.
JAMA Cardiology|October 12, 2022
Longer-Term All-Cause and Cardiovascular Mortality With Intensive Blood Pressure Control: A Secondary Analysis of a Randomized Clinical TrialByron C Jaeger, Adam P Bress, Joshua D Bundy, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|December 16, 2020
Clinical events and patient-reported outcome measures during CKD progression: findings from the Chronic Renal Insufficiency Cohort StudyMorgan E Grams, Aditya Surapaneni, Lawrence J Appel, et al.
Journal of the American Society of Nephrology : JASN|July 21, 2019
Implications of Early Decline in eGFR due to Intensive BP Control for Cardiovascular Outcomes in SPRINTSrinivasan Beddhu, Jincheng Shen, Alfred K Cheung, et al.
Current Cardiology Reports|August 16, 2021
Commentary on the KDIGO 2021 Clinical Practice Guideline for the Management of Blood Pressure in CKDJohannes F E Mann, Tara I Chang, William C Cushman, et al.
Pageof 27

Showing results (221-230 of 262) with videos related to

Sort By:
Pageof 27
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|September 20, 2021
Kidney Disease, Hypertension Treatment, and Cerebral Perfusion and StructureManjula Kurella Tamura, Sarah Gaussoin, Nicholas M Pajewski, et al.
Circulation|October 13, 2017
Influence of Baseline Diastolic Blood Pressure on Effects of Intensive Compared With Standard Blood Pressure ControlSrinivasan Beddhu, Glenn M Chertow, Alfred K Cheung, et al.
Annals of Internal Medicine|September 5, 2017
Effects of Intensive Systolic Blood Pressure Control on Kidney and Cardiovascular Outcomes in Persons Without Kidney Disease: A Secondary Analysis of a Randomized TrialSrinivasan Beddhu, Michael V Rocco, Robert Toto, et al.
Clinical Journal of the American Society of Nephrology : CJASN|April 30, 2020
Kidney Functional Magnetic Resonance Imaging and Change in eGFR in Individuals with CKDAnand Srivastava, Xuan Cai, Jungwha Lee, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|November 17, 2021
Plasma amyloid beta, neurofilament light chain, and total tau in the Systolic Blood Pressure Intervention Trial (SPRINT)Nicholas M Pajewski, Fanny M Elahi, Manjula Kurella Tamura, et al.
Clinical Journal of the American Society of Nephrology : CJASN|November 15, 2018
PTH, FGF23, and Intensive Blood Pressure Lowering in Chronic Kidney Disease Participants in SPRINTCharles Ginsberg, Timothy E Craven, Michel B Chonchol, et al.
JAMA Cardiology|October 12, 2022
Longer-Term All-Cause and Cardiovascular Mortality With Intensive Blood Pressure Control: A Secondary Analysis of a Randomized Clinical TrialByron C Jaeger, Adam P Bress, Joshua D Bundy, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|December 16, 2020
Clinical events and patient-reported outcome measures during CKD progression: findings from the Chronic Renal Insufficiency Cohort StudyMorgan E Grams, Aditya Surapaneni, Lawrence J Appel, et al.
Journal of the American Society of Nephrology : JASN|July 21, 2019
Implications of Early Decline in eGFR due to Intensive BP Control for Cardiovascular Outcomes in SPRINTSrinivasan Beddhu, Jincheng Shen, Alfred K Cheung, et al.
Current Cardiology Reports|August 16, 2021
Commentary on the KDIGO 2021 Clinical Practice Guideline for the Management of Blood Pressure in CKDJohannes F E Mann, Tara I Chang, William C Cushman, et al.
Pageof 27